Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... to evaluate the Company's once-daily inhaled liposomal ciprofloxacin administered via nebulizer in patients with non-cystic fibrosis bronchiectasis are progressing, with international ...
2009 NOV 16 ... trial comparing 60 mg of denufosol to placebo, administered three-times daily by jet nebulizer, in a targeted 450 CF patients. The Company expects to have top-line results from ...
2009 SEP 21 ... and efficacy of inhaled Aeroquin administered for 28 days using an Investigational eFlow Nebulizer System (PARI Pharma GmbH). Patients were then followed for an additional 28 days after ...
2009 SEP 28 ... aerosol formulation of levofloxacin delivered by an optimized Investigational eFlow Nebulizer System from PARI Pharma. In the Mpex cystic fibrosis trial, nebulized Aeroquin met the ...
2009 NOV 1 ... methods used by cystic fibrosis (CF) patients in Belgium. A questionnaire about type of nebulizer, methods, and frequency of cleaning, disinfection, and drying was established by ...
2009 OCT 12 ... all PARI LC reusable nebulizers. PARI's PEP S can be used alone or in combination with nebulizer therapies for airway clearance and lung strengthening exercises by cystic fibrosis ...
2009 NOV 2 ... aerosols are commonly used in mechanically ventilated patients. The position of the nebulizer in the ventilator circuit and the humidification of inhaled gases can influence the ...
2009 OCT 20 ... in vineyards. Males respond to the female-produced sex pheromone released from a piezo nebulizer in a dose-dependent manner in a wind tunnel: < 50% arrive at the source at 5-50 ...
2009 NOV 2 ... and a respiratory rate that kept PCO2 between 35 and 45 mm Hg. Chest physiotherapy, nebulizer treatments, and frequent suctioning were undertaken. Baseline arterial blood gas ...
2009 NOV 17 ... at concentrations of 5x10(8) each were sprayed into one side of the chamber using a nebulizer and the sprayed samples were collected by an impinger air-sampler on the other side. MTB ...
2009 NOV 1 ... ®) because of a reduced nebulization time and easier handling compared to a classic nebulizer-compressor combination." "Mesh technology may be vulnerable, however. ...
2009 NOV 27 ... investigators in the United States report."A high efficiency desolvating nebulizer system was employed to maximize ICP-MS sensitivity similar to 10 cps/fg. The three sigma ...
2009 SEP 28 ... observation period. ARIKACE and placebo were administered once daily using an eFlow Nebulizer System (PARI Pharma GmbH), a novel, highly efficient, portable aerosol delivery system. ...
2009 NOV 2 ... 70 mg, 140 mg and 560 mg doses using a novel inhalation device, the eFlow=AE Electronic Nebulizer (PARI Pharma GmbH). This study included member institutions of the Cystic Fibrosis ...
2009 SEP 28 ... of the disease by 2015. The study shows that patients who inhale interferon through a nebulizer can reduce their disease's transmissibility during the first few weeks of treatment. ...
Subject: NYU Langone Medical Center / New York University School of Medicine
2009 NOV 1 ... productivity and improve day-to-day reproducibility. Mass flow control (MFC) of the nebulizer gas is offered as an option for new instruments and can be retrofitted to existing ...
